Search Results - "Santoni-Rugiu, Eric"

Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors.

Authors: Egebjerg, Kristian Spanggaard, Iben Ahlborn, Lise Barlebo et al.

Source: BMC Cancer. 8/6/2025, Vol. 25 Issue 1, p1-11. 11p.

Improvement of Diagnostics in NSCLC Patients with MET Exon 14 Mutations Using Complementary DNA/RNA-NGS and Identification of Two Novel Exonic Splicing Mutations.

Authors: Urbanska, Edyta Maria Doktor, Thomas Koed Melchior, Linea Cecilie et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 1, p106. 15p.

Clinical outcomes of ALK+ non-small cell lung cancer in Denmark.

Authors: Hansen, Karin Holmskov Johansen, Jakob Sidenius Urbanska, Edyta Maria et al.

Source: Acta Oncologica. Dec2023, Vol. 62 Issue 12, p1775-1783. 9p.

Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced ALK -Rearranged NSCLC.

Authors: Urbanska, Edyta Maria Koffeldt, Peter Rindom Grauslund, Morten et al.

Source: International Journal of Molecular Sciences. Jul2025, Vol. 26 Issue 13, p5969. 18p.

Ossifying thymoma associated with refractory myasthenia gravis.

Authors: SANTONI-RUGIU, ERIC RAVN, JESPER SEHESTED, MAXWELL et al.

Source: APMIS. Apr2010, Vol. 118 Issue 4, p334-336. 3p. 1 Color Photograph.

Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts.

Authors: Buhl, Ida Kappel Santoni-Rugiu, Eric Ravn, Jesper et al.

Source: PLoS ONE. 3/22/2018, Vol. 13 Issue 3, p1-18. 18p.

Bedside Post‐Mortem Tissue Biopsy: Diagnostic Approach in ICU Patients?

Authors: Toft, Birgitte Grønkær Gjerdrum, Lise Mette Rahbek Pedersen, Ulf Gøttrup et al.

Source: APMIS. Jan2026, Vol. 134 Issue 1, p1-3. 3p.

Molecular imaging in Libman-Sacks endocarditis.

Authors: Dahl, Anders Schaadt, Bente K. Santoni-Rugiu, Eric et al.

Source: Infectious Diseases. 2015, Vol. 47 Issue 4, p263-266. 4p. 2 Color Photographs, 2 Diagrams.

MicroRNAs as potential biomarkers in malignant pleural mesothelioma.

Authors: Santoni-Rugiu, Eric Andersen, Morten Grauslund, Morten

Source: Current Biomarker Findings. Jan2016, Vol. 6, p1-21. 21p.

Differences in RRM1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non-small-cell lung cancer.

Authors: Jakobsen, Jan N Santoni‐Rugiu, Eric Sørensen, Jens B

Source: Histopathology. Feb2014, Vol. 64 Issue 3, p412-420. 9p.

Lipcalin 2 is protective against E. coli pneumonia.

Authors: Hong Wu Santoni-Rugiu, Eric Ralfkiaer, Elisabeth et al.

Source: Respiratory Research. 2010, Vol. 11, p96-103. 8p.

Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion.

Authors: Santoni-Rugiu, Eric Jelnes, Peter Thorgeirsson, Snorri S. et al.

Source: APMIS. Nov/Dec2005, Vol. 113 Issue 11/12, p876-902. 27p. 1 Color Photograph, 1 Diagram, 2 Charts.

Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR -Mutated NSCLC.

Authors: Urbanska, Edyta M. Grauslund, Morten Koffeldt, Peter R. et al.

Source: International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 17, p13077. 25p.

Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant Mesothelioma.

Authors: Santoni-Rugiu, Eric Lü, Maya Jeje Schuang Jakobsen, Jan Nyrop et al.

Source: International Journal of Molecular Sciences. Dec2021, Vol. 22 Issue 23, p12868. 1p.

Loss of miR-10a Activates Lpo and Collaborates with Activated Wnt Signaling in Inducing Intestinal Neoplasia in Female Mice.

Authors: Stadthagen, Gustavo Tehler, Disa Høyland-Kroghsbo, Nina Molin et al.

Source: PLoS Genetics. Oct2013, Vol. 9 Issue 10, p1-12. 12p.

Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance.

Authors: Santoni-Rugiu, Eric Melchior, Linea C. Urbanska, Edyta M. et al.

Source: Cancers. Jul2019, Vol. 11 Issue 7, p923-923. 1p.

Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report

Authors: Rossing, Henrik H. Grauslund, Morten Urbanska, Edyta M. et al.

Source: BMC Research Notes. 2013, Vol. 6 Issue 1, p1-17. 17p. 2 Color Photographs, 1 Black and White Photograph, 2 Graphs.

Safety Pharmacology, Toxicology and Pharmacokinetic Assessment of Human Gc Globulin (Vitamin D Binding Protein).

Authors: Pihl, Tina Holberg Jørgensen, Charlotte Sværke Santoni-Rugiu, Eric et al.

Source: Basic & Clinical Pharmacology & Toxicology. Nov2010, Vol. 107 Issue 5, p853-860. 8p. 1 Color Photograph, 3 Charts, 2 Graphs.

Are differentially expressed micro RNAs useful in the diagnostics of malignant pleural mesothelioma?

Authors: Andersen, Morten Grauslund, Morten Muhammad-Ali, Marwa et al.

Source: APMIS. Sep2012, Vol. 120 Issue 9, p767-769. 3p.

The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic Target.

Authors: Çakılkaya, Pınar Sørensen, Rikke Raagaard Jürgensen, Henrik Jessen et al.

Source: International Journal of Molecular Sciences. Nov2021, Vol. 22 Issue 21, p11452. 1p.